26 Apr Dr. Sebag’s Research on Vision Degrading Myodesopsia (Floaters) Published in Progress in Retinal and Eye Research Journal
To date, most doctors considered ‘floaters’ to be little more than nuisances. However, recent studies have shown that there can be severe effects on vision, specifically the ability to discern shades of gray, which is an important component of vision. This condition has been named “Vision Degrading Myodesopsia”, to distinguish it from benign floaters. A comprehensive review article (https://doi:10.1016/j.preteyeres.2020.100847) was recently published in the highest impact journal in Ophthalmology that summarizes the present state of knowledge regarding vitreous in health and disease as related to Vision Degrading Myodesopsia (clinically significant floaters). Currently available treatment options are described, and future directions are outlined.
- Vitreous fills the center of the eye with a clear solid gel during youth.
- Myopia in youth and posterior vitreous detachment in aging cause vitreous floaters.
- Vitreous opacities that cause floaters also degrade contrast sensitivity function.
- Degradation in contrast sensitivity function impacts vision and quality of life.
- Vitrectomy normalizes vision and improves quality of life cost-effectively.
- Laser therapies or pharmacologic vitreolysis might replace surgery in the future.
Read the article here: https://www.sciencedirect.com/science/article/abs/pii/S1350946220300197?via%3Dihub